Progression to dementia in a population with amnestic mild cognitive impairment: Clinical variables associated with conversion

Functional Neurology

Volumn 27, Issue 1, 2012, Pages 49-54

  Mauri, Marco ^a   Sinforiani, Elena ^b   Zucchella, Chiara ^b   Cuzzoni, Maria Giovanna ^a   Bono, Giorgio ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Dementia; Memory; Mild cognitive impairment

Indexed keywords

ADULT; AGED; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; PROGNOSIS; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; AMNESIA; DEMENTIA; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MENTAL DISORDERS; MILD COGNITIVE IMPAIRMENT; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 84862616549     PISSN: 03935264     EISSN: 19713274     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Chong MS, Sahadevan S. Preclinical Alzheimer's disease: diagnosis and prediction of progression. Lancet Neurol 2005; 4:576-579
2. Petersen RC, Doody R, Kurz A et al. Current concepts in mild cognitive impairment: clinical characterization and outcome. Arch Neurol 2001; 58:1985-1992
3. Dubois B, Feldman HH, Jacova C et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6:734-746
4. Palumbo B, Siepi D, Sabalich I, Tranfaglia C, Parnetti L. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease? Funct Neurol 2008; 23: 93-96
5. Mauri M, Sinforiani E, Bono G et al. Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and mild cognitive impairment. Funct Neurol 2006; 21: 223-228
6. Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 2007; 68:1588-1595
7. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the Cardiovascular Health Study. JAMA 2002; 288: 1475-1483
8. Gallagher D, Coen R, Kilroy D et al. Anxiety and behavioural disturbance as markers of prodromal Alzheimer's disease in patients with mild cognitive impairment. Int J Geriatric Psychiatry 2011; 26:166-172
9. Palmer K, Di Iulio F, Varsi AE et al. Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy. Journal of Alzheimers Dis 2010; 20:175-183
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
11. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140:566-572
12. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994; 57:416-418
13. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, et al. Research criteria for subcortical vascular dementia in clinical trials. J. Neural Transm Suppl 2000; 59:23-30
14. McKeith I, Dickson DW, Lowe J et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65:1863-1872
15. Rossi ER, Joachim C, Smith AD, Frisoni GB. The CTbased radial width of the temporal horn: pathological validation in AD without cerebrovascular disease. Int J Geriat Psychiatry 2004; 19:570-574
16. Geroldi C, Galluzzi S, Testa C, Zanetti O, Frisoni GB. Validation study of a CT-based weighted rating scale for subcortical ischemic vascular disease in patients with mild cognitive deterioration. Eur Neurol 2003; 49:193-209
17. Louis ED, Tang MX, Mayeux R. Parkinsonian signs in older people in a community-based study: risk of incident dementia. Arch Neurol 2004; 61:1273-1276
18. Yesavage JA, Brink TL, Rose TL et al Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982-1983; 17:37-49
19. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314
20. Schneider LS, Tariot PN, Lyketsos CG et al. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry. 2001;9:346-360
21. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
22. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271-276
23. Carlesimo GA, Caltagirone C, Gainotti G. The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. Eur Neurol 1996; 36:378-384
24. Mayeux R, Reitz C, Brickman AM et al. Operationalizing diagnostic criteria for Alzheimer's disease and other agerelated cognitive impairment-Part 1. Alzheimers Dement 2011;7:15-34
25. Eussen SJ, de Groot LC, Joosten LW et al. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am J Clin Nutr 2006;84:361-370
26. Dubois B, Feldman HH, Jacova C et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 2010; 9: 1118-1127
27. Li J, Wang YJ, Zhang M et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology 2011; 76: 1485-1491
28. Forti P, Maioli F, Pisacane N, Rietti E, Montesi F, Ravaglia G. Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment. Arch Gerontol Geriat 2007;44 (Suppl 1):155-165
29. Apostolova LG, Cummings JL. Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dement Geriatr Cogn Disord 2008; 25:115-126
30. Oksengard AR, Cavallin L, Axelsson R et al. Lack of accuracy for the proposed 'Dubois criteria' in Alzheimer's disease: a validation study from the Swedish brain power initiative. Dement Geriatr Cogn Disord 2010;30:374-380
31. Albert MS, DeKosky ST, Dickson D et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging and Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270-279